Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial.

The oncologist·2026

Same author

Methodological Approaches to Real-World Evidence Generation for Glucagon-like Peptide-1-Based Therapies: Synopsis of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.

Annals of internal medicine·2026

Same author

Glucagon-Like Peptide-1 Receptor Agonists and Cardiovascular Events in Adults With Obesity and Autoimmune Disease: A Target Trial Emulation.

Journal of the American Heart Association·2026

Same author

Socioeconomic and Clinical Determinants Driving Access to BRCA Genetic Testing in Cancer : A Case-Control Study Using Observational Electronic Health Records Across Multiple Sites.

medRxiv : the preprint server for health sciences·2026

Same author

Cluster Randomized Controlled Trial of Intensive Systolic Blood Pressure Control in Patients With Renal Cell or Thyroid Cancer Receiving VEGFR Tyrosine Kinase Inhibitors: ECOG-ACRIN EAQ191.

Hypertension (Dallas, Tex. : 1979)·2026

Same author

Real-world mortality and the effect of comorbidities on survival in glioblastoma: A database study using computed phenotypes for rapid, reliable patient identification.

Neuro-oncology advances·2026

Same journal

Patient-Reported Symptom Burden Among Thyroid Cancer Survivors: Retrospective Cohort Study.

JCO clinical cancer informatics·2026

Same journal

Rule-Based Algorithm to Identify Recurrent Non-Hodgkin Lymphoma in Electronic Health Data.

JCO clinical cancer informatics·2026

Same journal

Bayesian Methods for Subgroup Efficacy and Safety: Application to Japanese Patients in JAVELIN Renal 101.

JCO clinical cancer informatics·2026

Same journal

Effect of a Multidimensional Digital Health Intervention on Quality of Life in Breast Cancer Survivors: A Randomized Controlled Trial.

JCO clinical cancer informatics·2026

Same journal

Can Small Open-Source Language Models With Retrieval-Augmented Generation Match GPT-4 Performance in Breast Cancer Clinical Decision Support?

JCO clinical cancer informatics·2026

Same journal

Machine Learning Algorithm for the Detection of Tumor Microsatellite Instability Based on Multiomics Biomarkers.

JCO clinical cancer informatics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Sep 4, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Simulating Colorectal Cancer Trials Using Real-World Data.

Zhaoyi Chen^1,2, Hansi Zhang¹, Thomas J George³

¹Department of Health Outcomes & Biomedical Informatics, College of Medicine, University of Florida, Gainesville, FL.

JCO Clinical Cancer Informatics

|July 15, 2022

Summary

This summary is machine-generated.

This study used real-world data to simulate colorectal cancer trials, finding that simulated effectiveness and safety outcomes closely matched original trial results. This approach offers a robust method for analyzing cancer treatments using real-world evidence.

More Related Videos

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer

Published on: February 10, 2023

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Sep 4, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer

Published on: February 10, 2023

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

Area of Science:

Oncology
Clinical Trial Design
Real-World Evidence

Background:

Colorectal cancer (CRC) treatment relies on rigorous clinical trials.
Real-world data (RWD) offers a valuable resource for augmenting traditional trial methodologies.
Simulating clinical trials using RWD can provide insights into treatment effectiveness and safety.

Purpose of the Study:

To simulate colorectal cancer (CRC) clinical trials using a RWD-based approach.
To examine effectiveness and safety endpoints in different simulation scenarios.
To validate the use of RWD for robust clinical trial simulations.

Main Methods:

Identified five phase III metastatic CRC trials for simulation.
Utilized Electronic Health Record-derived RWD from the OneFlorida network.
Defined study populations and outcomes based on original trial protocols.
Simulated standard-of-care (SOC) arms and comparative effectiveness research (CER) arms.
Adjusted for random assignment, sampling, and dropout.
Measured effectiveness using overall survival (OS) and safety using severe adverse events (SAEs).

Main Results:

Conducted CER simulations for two trials and SOC simulations for three trials.
Simulated effect sizes remained stable across all runs.
Observed longer OS and higher mean SAEs in simulations compared to original trials.
Hazard ratios for death in CER simulations were similar to original trials.
Risk ratios for SAEs in the experimental arm were higher, suggesting potential toxicity.
SAE rates were consistent across simulations and comparable to original trials.

Conclusions:

Successfully simulated five CRC trials using two distinct scenarios.
Demonstrated that RWD-based simulations can robustly generate comparable effectiveness and safety outcomes.
Validated the simulation approach for analyzing clinical trial data using real-world evidence.